FLCCC commends the company’s decision to not offer COVID-19 vaccinations to children five and younger, which lack safety data and have possibly serious side effects.
June 27, 2022
Mr. Randall Todd Jones
President/CEO, Publix Super Markets Inc.
3300 Publix Corporate Parkway
Lakeland, FL 33811-3311
Dear Mr. Jones,
We are writing to both commend and to vigorously applaud your company’s decision not to offer COVID-19 vaccinations to children five and younger. Although Publix has not yet detailed the reasons behind the decision, we are compelled to tell you that we believe this action will save many children from vaccine injury or death in the regions in which your business operates. The FDA’s approval of COVID vaccines for child as young as 6 months old constitutes a true and URGENT national health emergency. The risks far outweigh any benefits in terms of efficacy, given that children have a 99.995% recovery rate, and a body of medical literature indicates that almost zero healthy children under five years old have died from COVID. In this context, the risks are unacceptable. Here’s why: • Safety studies on COVID vaccines for kids were grossly underpowered and looked at too few subjects for insufficient periods of time. • Additionally, according to the government’s Vaccine Adverse Event Reporting System (VAERS), at least 58 children under 3 years old experienced life-threatening side effects from receiving the mRNA vaccines. (It is not yet known if any of these children died.) • In the Pfizer trial, 34 children became ill with COVID after being vaccinated—yet only 13 in the placebo group contracted the disease. • As of early June 2022, the CDC and FDA report (via VAERS) that nearly 50,000 American children (up to age 17) have suffered harm following a COVID shot. More than 7,500 kids have required hospitalization, or an emergency room visit due to their vaccine-correlated injury. • Since vaccines were approved for kids 6 and older, nearly two dozen children have reportedly died from receiving the vaccines. Some developed myocarditis, which has a mortality rate of 25-56% over a course of up to 10 years as heart failure progresses. • It is not yet known how these experimental vaccines will affect the development of children. Also, no human reproductive toxicity data has yet been published. 2 • Over one million adverse events related to the COVID vaccines have been reported across the country since the shots became available in late 2020. However, we believe that the number of those who have been vaccine-injured—or those who died—is much, much higher. As Robert F. Kennedy, Jr. observed in a recent letter to members of the FDA’s Vaccines and Related Biological Products Advisory Committee: “…the Pfizer shots in the 5-11-year range led to very poor efficacy; 31% according to the CDC and 12% after 7 weeks according to a massive database comprising over 1.3 million children (365,000 of whom were vaccinated) from the NY Department of Health. Five to 11- year-old children dropped into the negative efficacy range by 8 weeks after receiving the second dose. It is the largest COVID vaccine efficacy study in children ever published, using the highest quality, official data from NY state. There was a large, linear drop in efficacy seen with each successive week following full vaccination. Extremely narrow confidence intervals confirm the validity of these data. By 8 weeks following their second dose, vaccinated children were placed at higher risk of developing COVID than unvaccinated children. By 9 weeks, their risk was even higher. Despite data-free theories offered to minimize this finding, the indisputable fact is that being vaccinated placed these children in a higher risk category for a COVID infection than if they had never been vaccinated.”
